Edit ModuleEdit ModuleShow Tags
Edit ModuleShow Tags

Pittsburgh at the Forefront of The Brain Revolution

Alzheimer’s disease is the most expensive ailment to treat and the sixth-leading cause of death in the United States. Pittsburgh has become a battleground in the fight against the devastating illness, thanks to the decade-long quest of two Pittsburgh researchers whose work is on track to change the face of medicine and affect millions worldwide.



(page 1 of 3)


Editor’s note: Niki Kapsambelis is the author of “The Inheritance: A Family on the Front Lines of the Battle Against Alzheimer’s Disease,” which chronicles the story of Alzheimer’s research through the lens of the DeMoe family of North Dakota. Stricken with an extremely rare genetic mutation that guarantees early onset Alzheimer’s, the DeMoes have worked with the University of Pittsburgh since the early 2000s to significantly advance scientific understanding of the disease and most recently to pilot test experimental prevention drugs. Their bond with Pitt researchers — particularly Dr. William Klunk of the Alzheimer’s Disease Research Center — is detailed in “The Inheritance” and has helped the field move toward a cure.
 


 

In 1994, a soft-spoken young doctor with a keen interest in brain disorders approached a colleague at the University of Pittsburgh with an idea: He wanted to develop a way to view Alzheimer’s disease in a living patient.
 

What Bill Klunk had in mind was nothing short of revolutionary and maybe a tad bit quixotic. Alois Alzheimer had discovered the disease 88 years earlier, and for much of that time, very little was known about it — including how widespread and deadly it was.

Part of the reason for that fatal misunderstanding was that doctors couldn’t definitively diagnose Alzheimer’s until the patient died, when they were able to look at the brain under a microscope. Another part of the reason was that Alzheimer’s, like many seemingly intractable illnesses, is such a biologically complex disease.
When I was researching my book, “The Inheritance,” one doctor remarked to me that we know more about the outer reaches of the universe than the inner workings of the brain.

​Klunk wanted to change that, and with good reason: despite flying under the radar for a good chunk of the 20th century, Alzheimer’s now is the sixth-leading cause of death in the United States, affecting 5.4 million Americans. Developing effective treatment — not to mention a cure — has proven to be maddeningly elusive.
Researchers in the Alzheimer’s field knew they could better identify the disease’s biological underpinnings if they could see its progression in real time. In so doing, they’d be better able to develop more precise treatments to halt or even prevent it.

It was a task easier said than done, as Chester Mathis knew well. Mathis, a Pitt radiochemist, had been trying since the 1980s — first in California and later in Pittsburgh — to develop a compound that would highlight the abnormalities in an Alzheimer’s brain, without success. Despite his other accomplishments, that incomplete task stuck with him.

And so began a decade-long quest that propelled Bill Klunk and Chet Mathis into the company of other Pittsburgh doctors whose work would change the face of medicine and impact millions of people worldwide.

Maybe it’s a side effect of working in a city that forged steel to build the world’s infrastructure. Perhaps it’s a ripple effect from living among people who refuse to give up in the face of failure. Whatever the X-factor may be, Pittsburgh boasts an impressive history of medical breakthroughs, often against long odds — whether it’s the polio vaccine or a multi-organ transplant.

There are parallels between the quest for a polio vaccine and the search for an Alzheimer’s cure. During the post-World War II epidemic, polls showed that the only thing Americans feared more than polio was nuclear war. Today, polls indicate the only disease Americans fear more than Alzheimer’s is cancer — although Alzheimer’s kills more people than breast and prostate cancer combined.

For Klunk and Mathis, the formula for success was a combination of persistence, hard work and the quiet but unwavering support of a mentor. And through a touch of serendipity, that eventual breakthrough would find a portal to the public in the unlikely form of a quirky family from the oil fields of North Dakota who came to think of Pittsburgh as a second home.
 



Pitt’s Dr. Chester Mathis (left) and Dr. William Klunk (right) discovered Pittsburgh Compound B, which made it possible for researchers to view Alzheimer’s disease in a living brain. | Photo courtesy University of Pittsburgh
 

An unlikely pair

A Pennsylvania native, Bill Klunk was a geriatric psychiatrist who had been recruited to Pitt nine years earlier. He proposed a window into the progression of a disease that has baffled science since its discovery in 1906. Long assumed to be part of the natural aging process, Alzheimer’s symptoms — forgetfulness, loss of organizational skills, difficulty finding words and names, delusions, paranoia and mood swings, among others — mimic those of many other diseases. That was why a clinical diagnosis was so difficult; doctors had to confirm their hunches postmortem by slicing open the brain and using a microscope to view the rogue proteins that are the Alzheimer’s signature.

Chet Mathis came to Pitt in 1992, lured by the medical school’s reputation for excellence and the presence of a dedicated cyclotron, a 100-ton, $2 million particle accelerator used in radiochemistry.

When Klunk proposed developing a new compound, what he had in mind was a riff on what Mathis already had tried unsuccessfully earlier in his career: adding radioactive atoms (a process called “radiolabeling”) to a dye that would stick to amyloid, one of the two abnormal proteins that are found in an Alzheimer’s brain. When doctors scanned the patient’s brain, the amyloid — coated in radiolabeled dye — in theory would show up on a scan.

Basic biology was working against them, however, due to the blood-brain barrier — the body’s natural filtering system that bars most substances from crossing into the brain past a series of tightly joined cells. Doctors needed a recipe for a compound that would successfully breach that barrier and stick to amyloid, which forms cotton ball-like clumps between neurons and disrupts their ability to signal each other.

What followed in the next 10 years was nothing short of systematic failure for Klunk and Mathis. Compound after compound flopped — hundreds in all.

“There were a lot of lean years here,” Klunk says in his characteristically understated way.

Those years were potential career killers. When an academic scientist is a candidate for tenure or promotion, universities typically ask colleagues in related fields to offer feedback on that scientist’s publications and grants.

But Klunk wasn’t focused on establishing that kind of track record. He and Mathis were on a Holy Grail kind of quest, one critically important to the future of Alzheimer’s research — but not one many other scientists were willing to tackle. Fortunately for them, they had David Kupfer in their corner. Kupfer, chairman of Pitt’s Department of Psychiatry from 1983 through 2009, had recruited Klunk.

“The promissory note from me in recruiting young, bright people who are ambitious is to try to let them run with their passion and see if I can play the role of a facilitator and an older brother,” says Kupfer, now a distinguished professor emeritus.

Klunk and Mathis established a friendship outside the laboratory. The two took fly-fishing trips together, where their unspoken rule dictated that they could talk about anything except work.

“When times were tough, when we were trying to keep things going, the mantra to live by was: You can always talk about fishing at work, but you can’t talk about work while fishing,” Klunk jokes.

In fishing, life imitated their art. The men who worked weekends and evenings, long hours in the lab in search of the elusive compound, would be wading into icy water at dawn on days when 30 degrees seemed warm. When dusk fell and it was too dark to see, they turned on their headlights and kept casting, casting.

Outside of Pittsburgh, despite their lack of success, other researchers were beginning to take notice. Many quietly pleaded with Kupfer to allow the quest to continue because of its importance to the rest of the field.

Finally in 2000 — after failing for nearly a decade — a long-awaited breakthrough occurred. The duo swapped out their original base molecule, known as “Congo Red,” for a simpler one that carried only a single positive charge. Within months, Mathis and Klunk had created roughly 100 derivatives of their compound, the most successful of which would come to be known as “Pittsburgh Compound B,” or PiB. On Valentine’s Day 2002, they collaborated with the Uppsala University PET Center in Sweden to test their creation in a human being. They would never know her name; all they would learn was that she was young and that memory problems had forced her to give up her career in health care.

When they learned that the experiment was a success, they wrote her a letter of thanks and celebrated with lunch at Fuel and Fuddle.

The first patient dosed with PiB would die from Alzheimer’s disease, proving that PiB could trace the disease in a living brain — an important milestone. Now, if the field could come up with a drug that attacked amyloid protein, they could watch its progress in real time, and compare it to any changes in a patient’s symptoms.
 

Edit ModuleShow Tags
Edit Module

Edit Module Edit ModuleShow TagsEdit ModuleShow Tags
Edit Module Edit ModuleShow Tags

The Latest

PM on KD: The Turkey Devonshire

PM Associate Editor and dining critic Hal B. Klein appeared on KDKA's Pittsburgh Today Live to discuss his new sandwich obsession, the Turkey Devonshire, and how it ended up on our February cover.

You Try It, Being a Meteorologist In Pittsburgh Isn't Easy

Aside from a Steelers loss, nothing seems to fire up Pittsburghers more than a blown weather forecast.

Our 50 Years: Why I Hate Nostalgia

Enjoying memories is fun – but a far cry from pining for the past.

Perspectives: Finding Grace in #MomLife

A Pittsburgh television reporter learns to embrace the imperfection that comes with being a working mom.

The 400-Word Review: Pledge

IFC Midnight's collegiate terror tale is mostly for genre fans, but it lands a few decent punches.

Capel’s Basketball Resurrection Has the Zoo Rocking Again

Head coach Jeff Capel is restoring respectability and re-establishing the relationship between Pitt’s students and Pitt’s student athletes.

Why Did No One Tell Me Cirque du Soleil is Awesome

A skeptical novice takes in the troupe's "Corteo" production and is stunned at his own delight.

Three Rivers Champion: Julius Boatwright

Boatwright works to connect everyone who needs it with mental health support.

Turkey Devonshire: Reviving a Classic Pittsburgh Sandwich

The once-famous sandwich originated here but now is largely forgotten. We dive into its history and argue that it's time for a revival.

Navigating the Future of Public Transit in Pittsburgh

Six Pittsburghers share their struggles and hopes for the region’s public transit system.

Why Jamison Farm Is a “A Napa Valley for Sheep”

How a former coal miner and his wife use the resources atop rolling Westmoreland County hills to produce the best lamb in the United States.

Pittsburgh Restaurant Review: Fish nor Fowl

The sixth standalone concept from the Richard DeShantz Restaurant Group, is DeShantz’s most exciting restaurant yet.

Our 50 Years: When We Tried to Predict the Future

25 years ago, we predicted what the Pittsburgh of 2019 would look like. We were ... close?

Help Pay Tribute to a Pittsburgh Jazz Legend

Mary Lou Williams began as a teenage piano prodigy in the Hill District and made it to Carnegie Hall and beyond. This month, you can discover her musical legacy.

Their's was a Starry-Eyed Pittsburgh Romance

John Brashear dedicated his life to science — and his wife, Phoebe.
Edit Module
Edit ModuleShow Tags


You Try It, Being a Meteorologist In Pittsburgh Isn't Easy

You Try It, Being a Meteorologist In Pittsburgh Isn't Easy

Aside from a Steelers loss, nothing seems to fire up Pittsburghers more than a blown weather forecast.

Comments

Our 50 Years: Why I Hate Nostalgia

Our 50 Years: Why I Hate Nostalgia

Enjoying memories is fun – but a far cry from pining for the past.

Comments


All the foodie news that's fit to blog
Fresh Fest Beerfest Is Set to Return to Pittsburgh

Fresh Fest Beerfest Is Set to Return to Pittsburgh

The country's first black brewfest looks to double in size this year.

Comments

Pittsburgh Chef Moves: Csilla Thackray Headed to Legume Bistro

Pittsburgh Chef Moves: Csilla Thackray Headed to Legume Bistro

Thackray's departure from The Vandal will result in a new menu at that Lawrenceville restaurant.

Comments


Not just good stuff. Great stuff.
Fitness: Five Great Trails to Run in the Fall in Pittsburgh

Fitness: Five Great Trails to Run in the Fall in Pittsburgh

Don’t resign yourself to the gym treadmills just yet – fall is one of the best times of the year to get outside and pound the pavement, surrounded by falling leaves and the possibility of grabbing a hot latte on the way home.

Comments

Love Sourdough? Find the Best There Is at These Five Bake Shops

Love Sourdough? Find the Best There Is at These Five Bake Shops

We dove into the local artisan bread scene to find the best places that bake naturally leavened bread in Pittsburgh.

Comments


Why Did No One Tell Me Cirque du Soleil is Awesome

Why Did No One Tell Me Cirque du Soleil is Awesome

A skeptical novice takes in the troupe's "Corteo" production and is stunned at his own delight.

Comments

My New Neighborhood Bar is The Birmingham Bridge Tavern

My New Neighborhood Bar is The Birmingham Bridge Tavern

After settling into a new neighborhood, PM nightlife editor Sean Collier sings the praises of his go-to corner bar.

Comments


Mike Prisuta's Sports Section

A weekly look at the games people are playing and the people who are playing them.
Capel’s Basketball Resurrection Has the Zoo Rocking Again

Capel’s Basketball Resurrection Has the Zoo Rocking Again

Head coach Jeff Capel is restoring respectability and re-establishing the relationship between Pitt’s students and Pitt’s student athletes.

Comments

Steelers' Organization Shares Blame for Brown Debacle

Steelers' Organization Shares Blame for Brown Debacle

For years now, the Steelers have been working around Brown’s maladaptive tendencies from Monday through Saturday and throwing him the ball on Sunday and hoping for the best.

Comments


The movies that are playing in Pittsburgh –– and, more importantly, whether or not they're worth your time.
The 400-Word Review: Pledge

The 400-Word Review: Pledge

IFC Midnight's collegiate terror tale is mostly for genre fans, but it lands a few decent punches.

Comments

The 400-Word Review: Glass

The 400-Word Review: Glass

M. Night Shyamalan's crossover film lands with a splat, as the filmmaker once again can't resist his worst impulses.

Comments


Everything you need to know about getting married in Pittsburgh today.
Pop Culture Touches Made These Weddings Extra Special

Pop Culture Touches Made These Weddings Extra Special

Whether you love all things Disney, “Game of Thrones” or “Star Wars,” there are lots of ways to add some personal — and fun — details into your wedding day.

Comments

It’s a Hockey Wedding in Pittsburgh

It’s a Hockey Wedding in Pittsburgh

This Pittsburgh couple was brought together by their love of hockey — and what better way to celebrate their New Year’s Eve wedding than with an outdoor game?

Comments


Weekly inspiration for your home from the editors of Pittsburgh Magazine
Up for Auction: Luxury 200-Acre Ligonier Estate Owned by Former EDMC Exec

Up for Auction: Luxury 200-Acre Ligonier Estate Owned by Former EDMC Exec

Woodmere is one of four high-end properties owned by Robert Knutson scheduled to hit the auction block this week.

Comments

The Top Five HOME Stories of 2018

The Top Five HOME Stories of 2018

Take a look back at the biggest stories to come out of Pittsburgh’s home and design industry.

Comments